In this special report, Drug Store News takes an in-depth look at community pharmacy and its growing role in helping to lower healthcare costs and expand patient access in the United States.
CRN's Steve Mister is one of six new members recently welcomed to the C100. According to Mister, the C100 provides CRN with new opportunities to collaborate.
The retail pharmacy industry is "enthusiastic to help leverage pharmacy to improve Americans’ health and well-being," NACDS president and CEO Steven Anderson noted regarding Trump's health nominations. "NACDS has a powerful story to tell."
GPhA president and CEO Chip Davis called for passage of the 21st Century Cures Act, which is headed to the House of Representatives this week, citing its funding for an act that would work to address the prescription drug abuse epidemic.
Presidential election of Donald Trump not the only thing to look at beginning in 2017.
Aurobindo has introduced a new label design as the company continues to eclipse market growth predictions, most recently moving into the Top 6 among all generic companies in prescriptions dispensed, according to QuintilesIMS National Prescription Audit data from August.
The Generic Drug User Fee Agreement, enacted under the Food and Drug Administration Safety and Innovation Act of 2012, has generated some $1.5 billion in user fees and has seen 1,992 approvals issued.
Biosimilars are expected to save the healthcare system between $44 billion and $250 billion in the next 10 years.
Generic medications saved the U.S. healthcare system more money in 2015 than ever before, according to the eighth-annual “2016 Generic Drug Savings & Access in the United States Report,” compiled by Quintiles IMS Institute on behalf of the Generic Pharmaceutical Association. This year’s report found $227 billion saved by using generics in 2015.
Meter manufacturers today are differentiating their offerings with an accompanying adherence app or other technologies that will help diabetes patients better navigate their disease states.